Measuring the societal impacts of the COVID-19 response in BC

During the first wave of the COVID-19 pandemic, sweeping measures were implemented in BC, such as closing nonessential services and reducing in-classroom learning and child care.[1] These measures were effective in helping slow transmission and preserve hospital resources. However, these measures have also impacted population health and wellness, the health care system, the environment, the economy, and society in general. Recognizing the broad range of effects stemming from the response measures, BC public health leaders established the Unintended Consequences (UniCon) Working Group in April 2020 to measure and monitor the effects in order to guide decision making on how to reduce morbidity and mortality from COVID-19 while minimizing societal disruption (e.g., keeping schools open). The working group is made up of representatives from the Office of the Provincial Health Officer, the Ministry of Health, the Ministry of Mental Health and Addictions, the BCCDC, the regional health authorities, and the First Nations Health Authority.

Because the effects of COVID-19 response measures are not uniform across the population, it’s necessary to apply an equity lens when measuring them. COVID-19 response measures are likely to disproportionately impact people with fewer resources, poorer health, and those already experiencing discrimination, marginalization, and social exclusion. Racialized groups, households with lower incomes, and women, for example, are more likely to face financial difficulties, unemployment, food insecurity, increased violence, and discrimination.[2,3] These harms can accrue over time, particularly for younger populations.[4]

People who use drugs are a subpopulation acutely affected by COVID-19 response measures. Disruptions to the drug supply chain due to the pandemic response have resulted in growing toxicity and unpredictability of street drugs. As well, recommendations for physical distancing have reduced access to overdose prevention sites and increased the use of drugs without others around. From March to October 2020, there were 1232 illicit overdose deaths in BC compared to 263 deaths due to COVID-19.[5,6] Resources were developed to mitigate these unintended harms and better support people who use drugs during the pandemic.[7]

Not all COVID-19 response measures have resulted in unintended harms. Virtual health visits were scaled up quickly due to concerns of COVID-19 transmission; anecdotally, this improved access to health care services for people living in rural and remote settings. Evaluation of health outcomes will help inform how to optimize virtual delivery of health care services.

It is important to uphold the rights of Indigenous peoples in BC during the COVID-19 response, and the UniCon Working Group is engaging with urban Indigenous communities and organizations in meaningful partnership, including through formal Indigenous data governance. The goal is to highlight the differential impacts of response measures on Indigenous peoples and help create Indigenous-specific materials, including research, reports, and public-facing information that can point the way forward.

The breadth and inequitable burden of COVID-19 response measures necessitate a multisectoral approach to address. Highlighting the societal impact of COVID-19 response measures can help identify opportunities for greater collaboration to build a stronger and healthier society. 
—Jason Wong, MD, MPH, CCFP, FRCPC
BC Centre for Disease Control
—Naomi Dove, MD, MPH, FRCPC
Office of the Provincial Health Officer
—Brian Emerson, MD, MHSc
Office of the Provincial Health Officer
—Xibiao Ye, PhD
Office of the Provincial Health Officer
—River Chandler, MA
Office of the Provincial Health Officer
—Adrienne Bonfonti, MA, MCPM, PMP
Office of the Provincial Health Officer
—Rola Zahr, MPH RD
BC Centre for Disease Control
—Reka Gustafson, MD, MSc, MHSc, FRCPC
BC Centre for Disease Control
—Bonnie Henry, MD, MPH, FRCPC
Office of the Provincial Health Officer

hidden


This article is the opinion of the BC Centre for Disease Control and has not been peer reviewed by the BCMJ Editorial Board.


References

1.    Government of BC. Phase 1 – BC’s restart plan, 24 June 2020. Accessed 10 December 2020. www2.gov.bc.ca/gov/content/safety/emergency-preparedness-response-recovery/covid-19-provincial-support/phase-1.

2.    Glover RE, van Schalkwyk MCI, Akl EA, et al. A framework for identifying mitigating equity harms of COVID-19 policy interventions. J Clin Epidemiol 2020;128:35-48.

3.    Douglas M, Katikiredii SV, Taulbut M, et al. Mitigating the wider health effects of covid-19 pandemic response. BMJ 2020;369:m1557.

4.    United Nations. Policy Brief: The impact of COVID-19 on children, 15 April 2020. Accessed 14 December 2020. https://unsdg.un.org/sites/default/files/2020-04/160420_Covid_Children_Policy_Brief.pdf.

5.    BC Coroners Service. Illicit drug toxicity deaths in BC: January 1, 2010 to November 30, 2020. Accessed 4 January 2021. www2.gov.bc.ca/assets/gov/birth-adoption-death-marriage-and-divorce/deaths/coroners-service/statistical/illicit-drug.pdf.

6.    Government of British Columbia. Joint statement on BC’s COVID-19 response, latest updates, Oct 30, 2020. Accessed 9 December 2020. https://news.gov.bc.ca/releases/2020HLTH0058-001905.

7.    BC Centre for Disease Control. COVID-19: Harm reduction and overdose response, 8 July 2020. Accessed 12 December 2020. www.bccdc.ca/Health-Info-Site/Documents/COVID19-harm-reduction.pdf.

Jason Wong, MD, MPH, CCFP, FRCPC , Naomi Dove, MD, MPH, FRCPC, Brian Emerson, MD, MHSc, Xibiao Ye, PhD, River Chandler, MA, Adrienne Bonfonti, MA, MCPM, PMP, Rola Zahr, MPH RD, Réka Gustafson, MD, MSc, MHSc, FRCPC, Bonnie Henry, MD, MPH, FRCPC. Measuring the societal impacts of the COVID-19 response in BC. BCMJ, Vol. 63, No. 1, January, February, 2021, Page(s) 27 - BCCDC, COVID-19.



Above is the information needed to cite this article in your paper or presentation. The International Committee of Medical Journal Editors (ICMJE) recommends the following citation style, which is the now nearly universally accepted citation style for scientific papers:
Halpern SD, Ubel PA, Caplan AL, Marion DW, Palmer AM, Schiding JK, et al. Solid-organ transplantation in HIV-infected patients. N Engl J Med. 2002;347:284-7.

About the ICMJE and citation styles

The ICMJE is small group of editors of general medical journals who first met informally in Vancouver, British Columbia, in 1978 to establish guidelines for the format of manuscripts submitted to their journals. The group became known as the Vancouver Group. Its requirements for manuscripts, including formats for bibliographic references developed by the U.S. National Library of Medicine (NLM), were first published in 1979. The Vancouver Group expanded and evolved into the International Committee of Medical Journal Editors (ICMJE), which meets annually. The ICMJE created the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals to help authors and editors create and distribute accurate, clear, easily accessible reports of biomedical studies.

An alternate version of ICMJE style is to additionally list the month an issue number, but since most journals use continuous pagination, the shorter form provides sufficient information to locate the reference. The NLM now lists all authors.

BCMJ standard citation style is a slight modification of the ICMJE/NLM style, as follows:

  • Only the first three authors are listed, followed by "et al."
  • There is no period after the journal name.
  • Page numbers are not abbreviated.


For more information on the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, visit www.icmje.org

BCMJ Guidelines for Authors

Leave a Reply